BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
Stock Information for Achieve Life Sciences Inc.
Loading
Please wait while we load your information from QuoteMedia.